Yang Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yang Tan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Hong Liu
Department of Dermatology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China; Research Center for Skin Tissue Engineering of Chongqing Higher Education Institutions, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China
1 shared publication- Jinyi Chen
Department of Dermatology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China; Research Center for Skin Tissue Engineering of Chongqing Higher Education Institutions, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China
1 shared publication - Liang Wang
Department of Dermatology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China; Research Center for Skin Tissue Engineering of Chongqing Higher Education Institutions, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China
1 shared publication - Lingfei Li
Department of Dermatology, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China
1 shared publication - Nian Chen
Department of Dermatology Daping Hospital Army Medical University Chongqing China
1 shared publication - Qionghui Cheng
Department of Dermatology, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China; Research Center for Skin Tissue Engineering of Chongqing Higher Education Institutions, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China
1 shared publication
Latest Publications
- Open Access
- 22 November 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (1)
Novel genetic insight for psoriasis: integrative genome-wide analyses in 863 080 individuals and proteome-wide Mendelian randomization
Psoriasis affects a significant proportion of the worldwide population and causes an extremely heavy psychological and physical burden. The existing therapeutic schemes have many deficiencies such as limited efficacies and various side effects. Therefore, novel ways of treating psoriasis are urgently needed. A large-scale meta-analysis of psoriasis genome-wide association studies (GWAS) totaling 20 105 cases and 842 975 controls was conducted. Based on the GWAS results, Mendelian randomization (MR) analyses were then performed on three cis-protein quantitative trait loci (pQTL) data in blood. Furthermore, druggability verification and mouse knock-out models were utilized to explore the clinical value of screened proteins. We identified 42 genome-wide significant psoriasis risk variants (P < 5 × 10−8), of which 33 were previously unreported. MR analyses unveiled 19 unique circulating proteins that were associated with psoriasis, among which only AIF1, FCGR3A, NEU1, HSPA1A, TNXB, and ABO were the potential proteins that interacted with psoriasis risk after being analyzed with high evidence of colocalization (PP.H4 > 0.9). In addition, AIF1, FCGR3A, and HSPA1A have been finally determined to be feasible therapeutic targets for psoriasis after being confirmed by druggability verification and specific mouse knock-out models. This large-scale GWAS meta-analysis identified 33 new variants for psoriasis. This study announced that AIF1, FCGR3, and HSPA1A were the unexplored but material variants of psoriasis, thus providing novel and valuable targets for psoriasis treatment and broadening new orientation of drug development for psoriasis.
- 22 November 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 26 (1)
Open AccessNovel genetic insight for psoriasis: integrative genome-wide analyses in 863 080 individuals and proteome-wide Mendelian randomization
Psoriasis affects a significant proportion of the worldwide population and causes an extremely heavy psychological and physical burden. The existing therapeutic schemes have many deficiencies such as limited efficacies and various side effects. Therefore, novel ways of treating psoriasis are urgently needed. A large-scale meta-analysis of psoriasis genome-wide association studies (GWAS) totaling 20 105 cases and 842 975 controls was conducted. Based on the GWAS results, Mendelian randomization (MR) analyses were then performed on three cis-protein quantitative trait loci (pQTL) data in blood. Furthermore, druggability verification and mouse knock-out models were utilized to explore the clinical value of screened proteins. We identified 42 genome-wide significant psoriasis risk variants (P < 5 × 10−8), of which 33 were previously unreported. MR analyses unveiled 19 unique circulating proteins that were associated with psoriasis, among which only AIF1, FCGR3A, NEU1, HSPA1A, TNXB, and ABO were the potential proteins that interacted with psoriasis risk after being analyzed with high evidence of colocalization (PP.H4 > 0.9). In addition, AIF1, FCGR3A, and HSPA1A have been finally determined to be feasible therapeutic targets for psoriasis after being confirmed by druggability verification and specific mouse knock-out models. This large-scale GWAS meta-analysis identified 33 new variants for psoriasis. This study announced that AIF1, FCGR3, and HSPA1A were the unexplored but material variants of psoriasis, thus providing novel and valuable targets for psoriasis treatment and broadening new orientation of drug development for psoriasis.
- Open Access
- 21 November 2024
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 51, 104414
Combination treatment with photodynamic therapy and antibiotic in refractory cutaneous nocardiosis: A case report
- 21 November 2024
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 51, 104414
Open AccessCombination treatment with photodynamic therapy and antibiotic in refractory cutaneous nocardiosis: A case report